SEC Form 4 · accession 0001676930-19-000002
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Takashi Kei Kishimoto
Officer — Chief Scientific Officer
Period of report
Jan 7, 2019
Accepted (ET)
Feb 21, 2019 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 7, 2019 | M | 36,114 | $2.77 | A | 36,114 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.77 | Jan 7, 2019 | M | 36,114 | D | — | Sep 7, 2021 | Common Stock | 36,114 | 43,629 | D |
Explanation of responses
- F1The shares underlying the option are fully vested.